Forward PE Ratio: 15.46
The forward PE ratio is 15.46 as of Thursday, July 9, 2026.
Forward PE Ratio (15.46) = Close Price ($420.39) / Consensus Forward EPS ($26.91)
ELV Forward PE Ratio Metrics
FORWARD PE RATIO
15.46
ELV Competitors' Forward PE Ratio
Elevance Health Inc.
Market Cap
$91.29B
Forward PE Ratio
15.46
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Elevance Health Inc. (ELV) | $91.29B | 15.46 |
| HCA Healthcare, Inc. (HCA)vs › | $90.73B | 13.58 |
| McKesson Corporation (MCK)vs › | $92.82B | 20.99 |
| GSK plc (GSK)vs › | $105.09B | 14.68 |
| Cigna Corporation (CI)vs › | $77.19B | 9.51 |
| Medtronic plc (MDT)vs › | $105.46B | 14.86 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $68.81B | 14.31 |
| Boston Scientific Corporation (BSX)vs › | $66.87B | 13.33 |
| Bristol-Myers Squibb Company (BMY)vs › | $118.32B | 9.11 |
| Cencora, Inc. (COR)vs › | $58.85B | 17.41 |
Trailing vs Forward
Trailing P/E
17.7
reported TTM EPS
Forward P/E
15.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $26.91 implies +14.5% EPS growth vs the reported trailing $23.51.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $420.39 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $26.91 | $25.77 – $28.30 | 16 | 15.6x |
| 2027-12-31 | $29.31 | $28.70 – $31.21 | 16 | 14.3x |
| 2028-12-31 | $34.27 | $33.62 – $36.53 | 5 | 12.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Elevance Health Inc. (ELV)?
- The forward PE ratio for ELV stock is 15.46.
Related Metrics
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux